Issue 19, 2018

Long-term delivery of rhIGF-1 from biodegradable poly(lactic acid)/hydroxyapatite@Eudragit double-layer microspheres for prevention of bone loss and articular degeneration in C57BL/6 mice

Abstract

Insulin-like growth factor (IGF-1) has encouraged researchers to investigate its various potential therapeutic uses such as in the treatment of osteoporosis and repair of articular cartilage. The purpose of this study was to develop core–shell double-layer structural microspheres for the long-term delivery of rhIGF-1 for the prevention of bone loss and articular degeneration. rhIGF-1-loaded poly(lactic acid)/hydroxyapatite@Eudragit (PLA/HA@Eu) double-layer microspheres with a core–shell structure were formulated using poly(lactic acid) and hydroxyapatite by an oil-in-water-in-oil (w/o/w) technique. The in vitro release profiles of rhIGF-1 and the surface morphology and cytocompatibility of microspheres were investigated. In vitro release of rhIGF-1 from PLA/HA@Eu microspheres was maintained over 180 days. In vivo experiments were performed on male C57BL/6 mice with two different ages: adult mice (three months old) and old mice (ten months old). PLA/HA@Eu microspheres containing 1 mg rhIGF-1 were subcutaneously implanted into the back of mice. The rhIGF-1 amounts in the sera, livers and bones of mice were monitored for 6 months. The in vivo rhIGF-1 release patterns were similar to those observed from in vitro release. By analyzing the effects of rhIGF-1-loaded microspheres on bone mass in adult mice and cartilage in old mice via micro-CT and histological measurements, we observed beneficial trends. These results suggest that PLA/HA@Eu double-layer microspheres providing long-term delivery of rhIGF-1 were effective in systemic preventive therapy of bone loss in adult mice and delaying the progressive degeneration of articular cartilage in old mice. The long-term delivery strategy demonstrated herein may be a promising therapeutic approach for delaying osteoporosis and articular degeneration.

Graphical abstract: Long-term delivery of rhIGF-1 from biodegradable poly(lactic acid)/hydroxyapatite@Eudragit double-layer microspheres for prevention of bone loss and articular degeneration in C57BL/6 mice

Article information

Article type
Paper
Submitted
02 Feb 2018
Accepted
08 Apr 2018
First published
19 Apr 2018

J. Mater. Chem. B, 2018,6, 3085-3095

Long-term delivery of rhIGF-1 from biodegradable poly(lactic acid)/hydroxyapatite@Eudragit double-layer microspheres for prevention of bone loss and articular degeneration in C57BL/6 mice

R. Liu, Y. Chen, L. Liu, Y. Gong, M. Wang, S. Li, C. Chen and B. Yu, J. Mater. Chem. B, 2018, 6, 3085 DOI: 10.1039/C8TB00324F

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements